Pharma Stocks Outlook for the week – 17 to 21.10.2016

Pharma Stocks Outlook for the week – 17 to 21.10.2016 )

Click Here  & Register To Get 2 days Trial Tips
Free Intraday Tips : Join Our Whatsapp No : 9841986753

Earnings of pharmaceutical companies for the September quarter will be the major trigger
for the sector going forward. As such, the stocks of these companies might be subdued next
week, as investors maintain caution. The Nifty Pharma index is likely to trade with a negative
bias in the range of 11300-11550 points next week.

Among companies, Biocon and its subsidiary Syngene International will report their earnings
on Thursday. Biocon is expected to report a consolidated net profit of 1.52 bln Rupees for
Jul-Sep. The positive outlook on Biocon due to the recent approval for insulin glargine in
Japan, as well as positive news pertaining to its insulin manufacturing facility in Malaysia.
So many speculative investors are expect regulatory issues to weigh on the earnings of
pharmaceutical companies for the September quarter. Among the factors that may be
tracked in the companies' earnings would be the impact of a ban on over 300 fixed-dose
combinations of drugs, as well as price controls in the case of essential medicines.